01
HUMAN HEALTH

We invest in biotechnology companies leveraging breakthrough science to improve human health, and in companies building novel technology-enabled solutions to improve access to care and health outcomes while reducing costs to individuals and the healthcare system.

02
ANIMAL HEALTH

Through our Companion Funds, we invest in companies leveraging science, technology, and design to improve animal health.

03
PEOPLE

Solving complex problems in biomedicine and health requires a multidisciplinary team.

04
NOTEBOOK

Through the Digitalis Notebook, we write and publish to show the thinking that underpins our investments, and our work at Digitalis Commons and Digitalis Labs.